Orchid Pharma Limited
Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins; human and veterinary products; and antibiotics, including betalactam, m… Read more
Orchid Pharma Limited (ORCHPHARMA) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.009x
Based on the latest financial reports, Orchid Pharma Limited (ORCHPHARMA) has a cash flow conversion efficiency ratio of 0.009x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹115.10 Million) by net assets (₹12.74 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Orchid Pharma Limited - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how Orchid Pharma Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Orchid Pharma Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Orchid Pharma Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Husteel
KO:005010
|
-0.039x |
|
Mountain & I Acquisition Co Corp
NASDAQ:MCAA
|
-0.001x |
|
SBI
HE:SBI
|
0.008x |
|
Addvalue Technologies Ltd
F:DDU
|
0.025x |
|
Bald Eagle Gold Corp.
OTCQB:BADEF
|
-0.483x |
|
TONGDAO LIEP.GR. DL-0001
F:6WT
|
N/A |
|
Leatec Fine Ceramics Co Ltd
TWO:6127
|
-0.020x |
|
NexG Bhd
KLSE:5216
|
-0.108x |
Annual Cash Flow Conversion Efficiency for Orchid Pharma Limited (2004–2025)
The table below shows the annual cash flow conversion efficiency of Orchid Pharma Limited from 2004 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹12.67 Billion | ₹192.15 Million | 0.015x | -85.93% |
| 2024-03-31 | ₹11.69 Billion | ₹1.26 Billion | 0.108x | +304.58% |
| 2023-03-31 | ₹6.89 Billion | ₹183.38 Million | 0.027x | -81.36% |
| 2022-03-31 | ₹6.47 Billion | ₹924.75 Million | 0.143x | +295.42% |
| 2021-03-31 | ₹6.53 Billion | ₹235.86 Million | 0.036x | -65.76% |
| 2020-03-31 | ₹7.66 Billion | ₹808.03 Million | 0.105x | +717.65% |
| 2019-03-31 | ₹-7.04 Billion | ₹120.24 Million | -0.017x | -47.30% |
| 2018-03-31 | ₹-7.92 Billion | ₹91.81 Million | -0.012x | +98.65% |
| 2017-03-31 | ₹-4.67 Billion | ₹4.01 Billion | -0.859x | -119.85% |
| 2016-03-31 | ₹490.45 Million | ₹2.12 Billion | 4.327x | +679.20% |
| 2015-03-31 | ₹3.29 Billion | ₹-2.46 Billion | -0.747x | -353.59% |
| 2013-03-31 | ₹3.81 Billion | ₹1.12 Billion | 0.295x | -52.70% |
| 2012-03-31 | ₹11.83 Billion | ₹7.37 Billion | 0.623x | +100.87% |
| 2011-03-31 | ₹10.71 Billion | ₹3.32 Billion | 0.310x | +947.20% |
| 2010-03-31 | ₹9.38 Billion | ₹-343.17 Million | -0.037x | -150.53% |
| 2009-03-31 | ₹6.34 Billion | ₹459.01 Million | 0.072x | -77.10% |
| 2008-03-31 | ₹6.65 Billion | ₹2.10 Billion | 0.316x | +63.88% |
| 2007-03-31 | ₹4.85 Billion | ₹936.11 Million | 0.193x | +1627.98% |
| 2006-03-31 | ₹7.76 Billion | ₹-97.95 Million | -0.013x | -106.68% |
| 2005-03-31 | ₹4.61 Billion | ₹870.92 Million | 0.189x | +667.99% |
| 2004-03-31 | ₹4.10 Billion | ₹-136.54 Million | -0.033x | -- |